Substituted eneoxindoles and uses thereof
US12037342B2 · kind B2 · utility
0Cited by
9References
54Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2022 |
| Grant date | Jul 16, 2024 |
| Priority date | — |
| Expiry date | Aug 17, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain ene-oxindole compounds, pharmaceutical compositions comprising thereof. Also disclosed are methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.